Dorota G.
- Country
- Norway
- Department
- Oncology
Research Overview
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma
- Phase IB/II Study of Bortezomib and Temozolomide in Recurrent Grade IV Glioma with Unmethylated MGMT Promoter
Data & Insights
Has run more than one trial at 13 of 95 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment of gastrointestinal stromal tumors (GIST), focusing on innovative therapeutic approaches combining targeted therapies.
- Advanced GIST Management
- Combination Therapy Assessment
- Targeted Treatment Strategies
Their research encompasses novel treatment combinations for patients with gastrointestinal stromal tumors.
Neuro-Oncology
The investigator focuses on treating advanced brain tumors, particularly grade IV recurrent glioma including both glioblastoma and IDH mutated astrocytoma.
- Recurrent Glioma Treatment
- Combined Therapeutic Approaches
- Progressive Brain Tumor Management
Their work involves evaluating novel combination treatments for aggressive brain tumors.
Soft Tissue Sarcoma
The investigator conducts research in advanced dedifferentiated liposarcoma (DDLPS), exploring new therapeutic combinations for this rare soft tissue cancer.
- Advanced Sarcoma Treatment
- Innovative Therapy Combinations
- Rare Cancer Management
Their focus includes evaluating novel therapeutic approaches for patients with advanced liposarcoma.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.